STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
· statnews.com · popularity 34/100 · 0 similar stories today · Corporate News & M&A (Business & Finance)
Read the original at statnews.com →
Summary
Servier reports a surprise setback for a drug being tested for a form of muscular dystrophy that lacks treatment.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 1.